Published in Cancer on October 15, 1991
Rab11 in dysplasia of Barrett's epithelia. Yale J Biol Med (2000) 0.90
Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction. World J Surg (2003) 0.85
Spatial Predisposition of Dysplasia in Barrett's Esophagus Segments: A Pooled Analysis of the SURF and AIM Dysplasia Trials. Am J Gastroenterol (2015) 0.82
Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study. World J Surg Oncol (2009) 0.81
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
Smoking in China: findings of the 1996 National Prevalence Survey. JAMA (1999) 8.67
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res (1994) 4.51
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
Leukotrienes in the pathophysiology of kwashiorkor. Lancet (1993) 3.14
Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus (1997) 3.06
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer (2001) 3.02
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS (1997) 2.82
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem (1998) 2.72
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum (2009) 2.57
Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg (1992) 2.54
Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science (2001) 2.40
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28
Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol (2001) 2.20
Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14
Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol (1996) 2.14
Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis (2009) 2.04
Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer (1993) 2.01
Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg (1998) 1.99
Formation of complexes between polyvinyl pyrrolidones or polyethylene glycols and tannins, and their implication in gas production and true digestibility in in vitro techniques. Br J Nutr (1995) 1.96
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol (1989) 1.81
Hydrothermal recharge and discharge across 50 km guided by seamounts on a young ridge flank. Nature (2003) 1.79
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill (2014) 1.79
Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg (1998) 1.78
Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77
Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis (2009) 1.76
Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy (1999) 1.76
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75
Detection of fat in a renal cell carcinoma mimicking angiomyolipoma. Radiology (1993) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity (1997) 1.74
Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry (2002) 1.70
Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication. J Gastrointest Surg (1999) 1.69
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology (1992) 1.68
High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy (2006) 1.66
Research for effective global tobacco control in the 21st century: report of a working group convened during the 10th World Conference on Tobacco or Health. Tob Control (1998) 1.64
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64
The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem (2000) 1.63
Options in the management of esophageal perforation: analysis over a 12-year period. Dis Esophagus (2009) 1.63
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol (1999) 1.61
Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg (2000) 1.61
Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60
PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy (2007) 1.59
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol (2001) 1.56
The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.56
Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg (1999) 1.56
Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. Lancet (1994) 1.56
Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg (2001) 1.55
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53
Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc (1991) 1.52
Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J Hosp Infect (2009) 1.50
[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]. Dtsch Med Wochenschr (1996) 1.50
Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg (2006) 1.49
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49
Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer (1998) 1.49
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
Enucleation of submucosal tumors of the esophagus: minimally invasive versus open approach. Surg Endosc (2004) 1.46
Cancer of the esophagogastric junction. Surg Oncol (2000) 1.45
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun (1997) 1.44
New technique for temporary purse string suture in stapler anastomosis. Br J Surg (1990) 1.43
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Br J Cancer (2008) 1.42
Low-dose cost/benefit assessment--a view from Europe. Health Phys (1998) 1.42
p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol (2001) 1.42
A new concept in the surgical treatment of gastroesophageal reflux. Ann Surg (1983) 1.41
The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy? J Gastrointest Surg (2008) 1.41
Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg (2000) 1.41
Failure of antireflux surgery: causes and management strategies. Am J Surg (1996) 1.40
Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br (2007) 1.40
Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass. Am J Obstet Gynecol (2000) 1.40
Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar keratoderma. Pediatr Dermatol (2000) 1.38
[Position paper on transplant surgery in visceral surgery]. Chirurg (1999) 1.38
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet (2004) 1.38
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia (1984) 1.35
Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg (1994) 1.35
[Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg (1987) 1.35
Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon. Clin Microbiol Infect (2011) 1.33
Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer (1993) 1.33
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33